CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.96 HKD | -0.44% |
|
-5.49% | +23.25% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
China Shineway Pharmaceutical Group Limited is an investment holding company principally engaged in the research and development, manufacture and trading of modern Chinese medicines. Its main products include injections, soft capsules and granules. The Companyâs subsidiaries include Yuan Da International Limited, Hong Zhan International Limited and Shineway Pharmaceutical Sales Company Limited.
Sector
Pharmaceuticals
Calendar
2024-08-29
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
8.306
CNY
Average target price
13.01
CNY
Spread / Average Target
+56.66%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +23.25% | 866M | |
| +18.04% | 42.95B | |
| +16.92% | 21.38B | |
| +18.33% | 15.05B | |
| +19.27% | 14.45B | |
| +56.12% | 13.04B | |
| -0.05% | 6.79B | |
| -10.73% | 6.72B | |
| -8.87% | 5.73B | |
| +11.21% | 5.47B |
- Stock Market
- Equities
- 2877 Stock
- News China Shineway Pharmaceutical Group Limited
- Shineway Pharmaceutical's Q1 Turnover Rises 36%
